Position in ICLR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$17,371
New position
Shares Held
100
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#357
of 422 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Evelyn Partners Group Ltd holds $93,727,554 across 10 Diagnostics & Research names. ICLR ranks #9 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
117,349 | $58,834,093 | |
| 2 | DHR |
Danaher Corp /De/
|
97,590 | $18,588,941 | |
| 3 | WAT |
Waters Corp /De/
|
40,668 | $15,252,125 | |
| 4 | RDNT |
RadNet, Inc.
|
9,024 | $556,510 | |
| 5 | ILMN |
Illumina, Inc.
|
1,545 | $271,656 | |
| 6 | MTD |
Mettler Toledo International Inc/
|
87 | $111,143 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
91 | $47,905 | |
| 8 | A |
Agilent Technologies, Inc.
|
233 | $30,949 |
All Filings in ICLR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,371 | 100 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||